SAN FRANCISCO and PALO ALTO, Calif. – January 9, 2003 –Broadlane Inc., a leading provider of total cost management services to the healthcare industry, and Varian Medical Systems Inc. (NYSE: VAR), today announced they have executed a three-year agreement to provide Broadlane customer hospitals with access to advanced radiotherapy systems for treating cancer. Under the agreement, Varian Medical Systems, the world’s leading manufacturer of integrated cancer therapy systems, will offer Broadlane institutions a full range of radiotherapy products including Clinac™ medical linear accelerators, Millennium™ multi-leaf collimators and PortalVision™ electronic portal imaging systems. In addition, Broadlane customer hospitals will have access to Varian’s full range of radiotherapy accessories and software, as well as diagnostic imaging products from GE Medical Systems, which Varian distributes in North America under a special See and Treat Cancer Care™ partnership agreement. “Varian’s state-of-the-art radiotherapy products include systems for delivering SmartBeam™ IMRT (intensity modulated radiation therapy), an extremely precise form of treatment that targets cancer cells with high radiation doses while minimizing the exposure of healthy tissue,” said Timothy Guertin, president of Varian Medical Systems’ oncology business. “More than 185 cancer treatment centers around the world, from university hospitals to community-based clinics, have adopted SmartBeam IMRT. We’re looking forward to helping Broadlane customers do the same.” In addition to the actual hardware, Varian provides the software necessary for delivering IMRT, as well as education and training for radiation oncology professionals establishing IMRT programs. Varian was awarded the contract as part of Broadlane's intensive contract selection process, which focuses on delivering high-quality, cost-effective products and services to Broadlane's healthcare provider customers. To ensure that it selects the best products and vendors for its customers, Broadlane solicits input and direction from key end users, such as physicians and nurses, as well as hospital business leaders. Suppliers find particular value in contracting with Broadlane because of the company's strategy of involving clinical end users from the beginning of the contracting process. That means that buyers ultimately have a much deeper commitment to the contracts than is typical. “There have been tremendous advances in radiation therapy over the last five years, and Varian has been at the forefront of providing hospitals with new capabilities,” said William A. Thomas, head of Broadlane’s capital equipment contracting group. “This agreement enables us to provide our customers with access to the high caliber of cancer treatment equipment produced by Varian Medical Systems.”